Point Therapeutics Adjourns Meeting of Stockholders to February 12, 2008; DARA BioSciences, Inc. Stockholders Approve Merger with Point Therapeutics

WELLESLEY HILLS, Mass.--(BUSINESS WIRE)--Point Therapeutics, Inc. (NASDAQ: POTP) today announced that it has adjourned its annual meeting of stockholders, which commenced at 10 a.m. this morning, until Tuesday, February 12, 2008. At the February 12 meeting, Point stockholders will vote on several proposals in connection with the proposed merger with DARA Biosciences, Inc. The meeting was adjourned to allow for the solicitation of additional votes in favor of the proposals. While proxies received to date have been overwhelmingly in favor of the merger-related proposals, approval of a majority of the outstanding Point shares is necessary for certain of the proposals to be approved. Point attributes the shortfall primarily to the fact that the Company currently has a large and diverse stockholder base.